Anderson J P, O'Brien P Q, Hughes D C. "一种的合成方法" [P]. US Patent, US 11186165 B2, 2020-12-27.
发明人马晓峰,郭海燕,韩伟. "Method for the Synthesis of 2-(1-Methyl-1H-benzo[d]imidazol-2-yl)-3-(p-tolylamino)acrylonitrile" [P]. 中国发明专利, 专利号 CN 114772656 B, 授权公告日 2025-05-21.
发明人张德明,郭海燕,冯建国. "A Process for Preparing High-Purity 2-(1-Methyl-1H-benzo[d]imidazol-2-yl)-3-(p-tolylamino)acrylonitrile" [P]. 中国发明专利, 专利号 CN 113032616 A, 授权公告日 2020-01-21.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2015, 557, 2900-2907.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2022, 1146, 8450-8479.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 2-(1-Methyl-1H-benzo[d]imidazol-2-yl)-3-(p-tolylamino)acrylonitrile Using HRMS and NMR". Anal. Chim. Acta, 2015, 1584, (12), 2704-2718.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2025, 486, 5231-5252.